(Q68158363)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606991%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Disposition of antipyrine in patients with extensive metastatic liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606991%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference

G M Robertz-Vaupel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606991%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

K D Lindecken

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606991%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

T Edeki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606991%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

C Funke

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606991%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

S Belwon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606991%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

H J Dengler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606991%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606991%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

22 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606991%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606991%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606991%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

465-469

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606991%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00314851

22 September 2019

exact match

0 references

cites work

Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers

1 reference

12 December 2020

Antipyrine elimination and hepatic microsomal enzyme activity in patients with liver disease

1 reference

12 December 2020

Relationship between the metabolism of antipyrine, hexobarbital and theophylline in patients with liver disease as assessed by a 'cocktail' approach

1 reference

12 December 2020

Pharmacokinetics of benzodiazepine antagonist Ro 15-1788 in cirrhotic patients with moderate or severe liver dysfunction

1 reference

12 December 2020

Pharmacokinetics of adriamycin, adriamycinol, and antipyrine in patients with moderate tumor involvement of the liver

1 reference

12 December 2020

Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis

1 reference

12 December 2020

Norphenazone, a new metabolite of phenazone in human urine

1 reference

12 December 2020

HPLC Determination of Antipyrine Metabolites

1 reference

12 December 2020

4,4?-Dihydroxyphenazone as an urinary metabolite of phenazone in different species including man

1 reference

12 December 2020

Accurate Measurement of Liver, Kidney, and Spleen Volume and Mass by Computerized Axial Tomography

1 reference

12 December 2020

Drug metabolism in liver disease

1 reference

12 December 2020

Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration

1 reference

12 December 2020

Gas chromatographic-mass spectrometric assessment of the pharmacokinetics of amineptine and its main metabolite in volunteers with liver impairment

1 reference

12 December 2020

The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.

1 reference

12 December 2020

Assay of Antipyrine and Its Primary Metabolites in Plasma, Saliva and Urine by High-Performance Liquid Chromatography and Some Preliminary Results in Man

1 reference

12 December 2020

[Demonstration of a new reactive metabolite in metabolism of phenazone (antipyrine)]

1 reference

12 December 2020

Gross impairment of hepatic drug metabolism in a patient with chronic liver disease.

1 reference

12 December 2020

Determinants of serum antipyrine half-lives in patients with liver disease

1 reference

12 December 2020

Commentary: a physiological approach to hepatic drug clearance

1 reference

12 December 2020

Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver disease

1 reference

12 December 2020

Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand

1 reference

12 December 2020

Automated high-performance liquid chromatographic determination of antipyrine and its main metabolites in plasma, saliva and urine, including 4,4'-dihydroxyantipyrine

1 reference

12 December 2020

Factors influencing antipyrine elimination

1 reference

12 December 2020

The effects of age and liver disease on the disposition and elimination of diazepam in adult man

1 reference

12 December 2020

Quantitative Assessment of Hepatic Function by Breath Analysis after Oral Administration of [^14C]aminopyrine

1 reference

12 December 2020

Metabolism of Drugs. LXX. Further Study on Antipyrine Metabolism

1 reference

12 December 2020

The fate of antipyrine in man

1 reference

12 December 2020

Histological changes in the liver and indices of drug metabolism in alcoholics

1 reference

12 December 2020

Correlation of the plasma elimination of antipyrine and the appearance of 4-hydroxy antipyrine in the urine of man

1 reference

12 December 2020

Rapid and sensitive method for the determination of antipyrine in biological fluids by high-pressure liquid chromatography

1 reference

12 December 2020

Clearance of antipyrine-dependence of quantitative liver function.

1 reference

12 December 2020

Pharmacokinetics and metabolism of antipyrine (phenazone) after intravenous and oral administration.

1 reference

12 December 2020

Impairment of drug metabolism in patients with liver cancer

1 reference

12 December 2020

Abnormal drug metabolism after barbiturate and paracetamol overdose

1 reference

12 December 2020

Measurement of liver and spleen volume by computed tomography. Assessment of reproducibility and changes found following a selective distal splenorenal shunt

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00314851

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606991%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference